Rituximab in a child with relapsed Burkitt lymphoma [3]

Pediatric Blood and Cancer

Volumn 49, Issue 2, 2007, Pages 218-

  Bay, Ali ^a,b   Dogan, Murat ^a   Acikgoz, Mehmet ^a   Öner, Ahmet Faik ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b Arastirma Hastanesi Cocuk Hastaliklari Servisi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; CHILDHOOD CANCER; CLINICAL PROTOCOL; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ABDOMEN; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHEEK; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOTHERAPY; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION;

EID: 34447252848     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20957     Document Type: Letter

References (6)

1. Atra A, Gerrard M, Hobson R, et al. Outcome of relapsed or refractory childhood B-cell ALL and B-cell NHL treated with the UKCCSG 9003/9002 protocols. Br J Haematol 2001;112:965-996
2. Reiter A, Schrappe M, Tiemann M. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 1999;94:3294-3306.
3. Dormann S, Duffner U, Martini C, et al. Chronic myelopathy after combined chemo-radiotherapy in a patient with relapsed mediastinal B-cell lymphoma. Med Pediatr Oncol 2002;38:442-444.
4. Culic S, Culic V, Armanda V, et al. Anti-CD20 monoclonal antibody (Rituximab) for therapy of mediastinal CD20-positive large B-cell non-Hodgkin lymphoma with a local tumor extension into the lung of a 10-year-old girl. Pediatr Hematol Oncol 2003;20:339-344.
5. de Vries MJ, Veerman AJ, Zwaan CM. Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma. Br J Haematol 2004;125:414-415.
6. Okur FV, Oguz A, Karadeniz C, et al. Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphoma. Pediatr Hematol Oncol 2006;23:25-31.